ロード中...
E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
Clinical prognosis of metastasized colorectal carcinoma (CRC) is still not at desired levels and novel drugs are needed. Here, we focused on the multi-tyrosine kinase inhibitor E7080 (Lenvatinib) and assessed its therapeutic efficacy against human CRC cell lines in vitro and human CRC xenografts in...
保存先:
| 出版年: | Neoplasia |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4240916/ https://ncbi.nlm.nih.gov/pubmed/25425971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.09.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|